IBDEI0EF ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6636,1,4,0)
 ;;=4^C79.52
 ;;^UTILITY(U,$J,358.3,6636,2)
 ;;=^5001351
 ;;^UTILITY(U,$J,358.3,6637,0)
 ;;=C79.31^^30^396^112
 ;;^UTILITY(U,$J,358.3,6637,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6637,1,3,0)
 ;;=3^Malig Neop Brain,Secondary
 ;;^UTILITY(U,$J,358.3,6637,1,4,0)
 ;;=4^C79.31
 ;;^UTILITY(U,$J,358.3,6637,2)
 ;;=^5001347
 ;;^UTILITY(U,$J,358.3,6638,0)
 ;;=C79.72^^30^396^127
 ;;^UTILITY(U,$J,358.3,6638,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6638,1,3,0)
 ;;=3^Malig Neop Left Adrenal Gland,Secondary
 ;;^UTILITY(U,$J,358.3,6638,1,4,0)
 ;;=4^C79.72
 ;;^UTILITY(U,$J,358.3,6638,2)
 ;;=^5001357
 ;;^UTILITY(U,$J,358.3,6639,0)
 ;;=C78.02^^30^396^131
 ;;^UTILITY(U,$J,358.3,6639,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6639,1,3,0)
 ;;=3^Malig Neop Left Lung,Secondary
 ;;^UTILITY(U,$J,358.3,6639,1,4,0)
 ;;=4^C78.02
 ;;^UTILITY(U,$J,358.3,6639,2)
 ;;=^5001336
 ;;^UTILITY(U,$J,358.3,6640,0)
 ;;=C78.7^^30^396^136
 ;;^UTILITY(U,$J,358.3,6640,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6640,1,3,0)
 ;;=3^Malig Neop Liver/Intrahepatic Bile Duct,Secondary
 ;;^UTILITY(U,$J,358.3,6640,1,4,0)
 ;;=4^C78.7
 ;;^UTILITY(U,$J,358.3,6640,2)
 ;;=^5001339
 ;;^UTILITY(U,$J,358.3,6641,0)
 ;;=C79.71^^30^396^149
 ;;^UTILITY(U,$J,358.3,6641,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6641,1,3,0)
 ;;=3^Malig Neop Right Adrenal Gland,Secondary
 ;;^UTILITY(U,$J,358.3,6641,1,4,0)
 ;;=4^C79.71
 ;;^UTILITY(U,$J,358.3,6641,2)
 ;;=^5001356
 ;;^UTILITY(U,$J,358.3,6642,0)
 ;;=C78.01^^30^396^153
 ;;^UTILITY(U,$J,358.3,6642,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6642,1,3,0)
 ;;=3^Malig Neop Right Lung,Secondary
 ;;^UTILITY(U,$J,358.3,6642,1,4,0)
 ;;=4^C78.01
 ;;^UTILITY(U,$J,358.3,6642,2)
 ;;=^5001335
 ;;^UTILITY(U,$J,358.3,6643,0)
 ;;=C79.70^^30^396^104
 ;;^UTILITY(U,$J,358.3,6643,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6643,1,3,0)
 ;;=3^Malig Neop Adrenal Gland Unspec,Secondary
 ;;^UTILITY(U,$J,358.3,6643,1,4,0)
 ;;=4^C79.70
 ;;^UTILITY(U,$J,358.3,6643,2)
 ;;=^5001355
 ;;^UTILITY(U,$J,358.3,6644,0)
 ;;=C78.00^^30^396^137
 ;;^UTILITY(U,$J,358.3,6644,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6644,1,3,0)
 ;;=3^Malig Neop Lung Unspec,Secondary
 ;;^UTILITY(U,$J,358.3,6644,1,4,0)
 ;;=4^C78.00
 ;;^UTILITY(U,$J,358.3,6644,2)
 ;;=^5001334
 ;;^UTILITY(U,$J,358.3,6645,0)
 ;;=D57.1^^30^396^178
 ;;^UTILITY(U,$J,358.3,6645,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6645,1,3,0)
 ;;=3^Sickle-Cell Disease w/o Crisis
 ;;^UTILITY(U,$J,358.3,6645,1,4,0)
 ;;=4^D57.1
 ;;^UTILITY(U,$J,358.3,6645,2)
 ;;=^5002309
 ;;^UTILITY(U,$J,358.3,6646,0)
 ;;=D75.1^^30^396^176
 ;;^UTILITY(U,$J,358.3,6646,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6646,1,3,0)
 ;;=3^Polycythemia,Secondary
 ;;^UTILITY(U,$J,358.3,6646,1,4,0)
 ;;=4^D75.1
 ;;^UTILITY(U,$J,358.3,6646,2)
 ;;=^186856
 ;;^UTILITY(U,$J,358.3,6647,0)
 ;;=C90.30^^30^396^179
 ;;^UTILITY(U,$J,358.3,6647,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6647,1,3,0)
 ;;=3^Solitary Plasmacytoma,Not in Remission
 ;;^UTILITY(U,$J,358.3,6647,1,4,0)
 ;;=4^C90.30
 ;;^UTILITY(U,$J,358.3,6647,2)
 ;;=^5001759
 ;;^UTILITY(U,$J,358.3,6648,0)
 ;;=D56.3^^30^396^180
 ;;^UTILITY(U,$J,358.3,6648,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6648,1,3,0)
 ;;=3^Thalassemia Minor
 ;;^UTILITY(U,$J,358.3,6648,1,4,0)
 ;;=4^D56.3
 ;;^UTILITY(U,$J,358.3,6648,2)
 ;;=^340497
 ;;^UTILITY(U,$J,358.3,6649,0)
 ;;=D56.9^^30^396^181
 ;;^UTILITY(U,$J,358.3,6649,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6649,1,3,0)
 ;;=3^Thalassemia,Unspec
 ;;^UTILITY(U,$J,358.3,6649,1,4,0)
 ;;=4^D56.9
 ;;^UTILITY(U,$J,358.3,6649,2)
 ;;=^340606
